Background: Food-borne disease is a major public health problem affecting developed as well as developing countries. Inaccurately treated eggs can be one of its causes. So we designed this study to observe the possibility of transmission of pathogenic Gram-positive bacteria from market eggs to the community.Objectives: To identify different Gram-positive bacteria in eggs and to observe their antimicrobial susceptibility.Materials and Methods: This observational study was conducted in the department of Microbiology, Dhaka Medical College, Dhaka. Shells of 150 eggs collected from different markets of Dhaka city were tested. Bacteria were isolated and identified by culture and relevant biochemical tests.Results: Out of 150 egg shells, 120 (80%) yielded growth of different bacteria. Of them, Staphylococcus spp. were 80 (66.67%), Streptococcus spp. 8 (6.67%), Bacillus subtilis 20 (16.67%) and Bacillus cereus 12 (10%). Out of 80 Staphylococcus spp., 30 (25%) were Staphylococcus aureus and 50 (41.67%) were Staphylococcus saprophyticus. Most of the Gram-positive bacteria were sensitive to ciprofloxacin, ceftriaxone and imipenem. No MRSA and VRSA were found.Conclusion: It can be concluded from this study that Gram-positive bacteria from market eggs may be an important source of infection to the community.J Enam Med Col 2016; 6(1): 15-18
Cervical cancer remains a critical public health problem that is second only to breast cancer in overall disease burden for women throughout the world. 1 It is still an important cause of mortality and morbidity in the developing countries. 2 Universal deployment of organized or opportunistic screening with Pap cytology in high and middle income countries has been the primary reason for the substantial reductions in cervical cancer morbidity and mortality during the last 50 years. However, in many low income countries Pap cytology screening is yet to be effectively implemented or has failed to reduce cervical cancer rates to an appreciable extent. 3 Screening appears to benefit only a small fraction of women although a much larger percentage endures the inconvenience of the Pap test in order to avoid cervical cancer. 2 Human papilloma virus (HPV) infection is one of the most common sexually transmitted diseases worldwide. Up to 79 million of sexually active women worldwide will become infected with HPV during their lifetime. 4 To date, more than 120 genotypes of Human Papilloma virus (HPV) are known, but only high risk oncogen genotypes could induce a cancer. HPV 16 and 18 are implied in nearly 70% of cervical cancer around the world. 5 In Bangladesh, the annual number of cases of cervical cancer is 1 1 956 and death is 6 582. 6 A prophylactic vaccine to protect against the precancerous and cancerous lesions associated with HPV should save lives, reduce expensive diagnostic and t herapeutic interventions, and have substantial individual and collective benefits. 5 In this review paper, we discuss the type of cervical vaccine and its mechanism of action. Various reports of trial and vaccine impact on different categories of women are also discussed. Function of vaccineThe current HPV vaccines are based on virus-like particles (VLPs) t hat are formed b y HPV surface components (viral capsid). They are not infectious, because they lack t he virus' DNA. However, t hey Introduction 157
Background: Wound infections are global problem in the field of surgery associated with long hospital stay, higher treatment expenditure, morbidity and mortality. Objective: To isolate and identify the bacteria causing wound infection and to determine the antimicrobial susceptibility pattern. Methods: This retrospective study was conducted in the Department of Microbiology at Shaheed Suhrawady Medical College, Dhaka from January 2017 to December 2017 for a period of one (01) year. A total of 190 wound swabs were collected from the patients who were visited in outpatient department and were admitted at inpatient department with skin and soft tissue infection. Swabs from the wound were inoculated on appropriate media and cultured and the isolates were identified by standard procedures as needed. Antimicrobial susceptibility testing was done by disc diffusion method according to ‘The Clinical Laboratory Standard Institute’ guidelines. Results: In this study, out of 190 cases 115 (60.52%) were male and 75 (39.47%) were female and majority 85(44.73%) were in the age group of 16 to 30 years. A total number of 190 isolates were obtained, among which 124 (65.25%) were culture positive cases. Among the isolated organisms predominant bacteria was Staphylococcus aureus 68 (35.79%) followed by Escherichia coli 30 (15.79%), Pseudomonas 14 (7.37%), Klebsiella 6 (3.16%), Proteus 4 (2.10%) and Acinetobacter 2 (1.05%). Staphylococcus aureus was sensitive to linezolid (94.11%), vancomycin (88.23%) and amikacin (70.58%). Among the Gram negative isolates Escherichia coli was predominant and showed sensitivity to imipenem (80%), amikacin (70%), ceftazidime (60%), piperacillin+ tazobactum (56.66%), colistin (53.33%). Pseudomonas showed sensitivity to colistin (78.57%), imipenem (71.42%). Klebsiella showed sensitivity to imipenem (83.33%), amikacin (66.66%), piperacillin+ tazobactum (66.66%), and colistin(66.66%). Conclusion: Staphylococcus aureus was the most frequently isolated pathogen from wound swab and the antibiotic sensitivity pattern of various isolates will guide for appropriate selection of antibiotics against wound infection, so as to reduce the spread of resistant bacteria. J Shaheed Suhrawardy Med Coll, June 2019, Vol.11(1); 65-68
Nipah virus, a member of the genus Henipavirus, a new class of virus in the Paramyxoviridae
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.